The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.45
Bid: 18.00
Ask: 18.45
Change: 0.275 (1.51%)
Spread: 0.45 (2.50%)
Open: 18.00
High: 18.45
Low: 18.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of NGSoft

1 Mar 2021 07:00

RNS Number : 6021Q
BATM Advanced Communications Ld
01 March 2021
 

LEI: 213800FLQUB9J289RU66

1 March 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Update on Sale of NGSoft

 

Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021.

 

The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021.

 

NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEIFWAEFSEDE
Date   Source Headline
16th Dec 201012:57 pmRNSHolding(s) in Company
29th Nov 201011:30 amRNSDirectorate Change
10th Nov 20107:00 amRNSTrading Statement
28th Sep 20107:00 amRNSContract Win
13th Sep 20107:00 amRNSInterim Management Statement
10th Aug 20107:00 amRNSHalf Yearly Report
5th Aug 20107:00 amRNSInvestor Day
28th Jul 20107:00 amRNSNotice of Interim Results
28th Jun 20108:58 amRNSDirectorate Change
22nd Jun 201012:53 pmRNSResult of AGM
22nd Jun 20107:00 amRNSAGM Statement
14th Jun 20102:04 pmRNSHolding(s) in Company
2nd Jun 20102:50 pmRNSAnnual Information Update
20th May 201011:00 amRNSHolding(s) in Company
18th May 20104:25 pmRNSDirector/PDMR Shareholding
18th May 201011:24 amRNSDirector/PDMR Shareholding
18th May 20107:00 amRNSInterim Management Statement
12th May 20102:48 pmRNSNotice of IMS
30th Apr 20104:00 pmRNSAnnual Financial Report
22nd Apr 20107:00 amRNSLicensing Agreement
15th Mar 201010:47 amRNSHolding(s) in Company
15th Mar 201010:43 amRNSHolding(s) in Company
22nd Feb 201012:58 pmRNSDirector/PDMR Shareholding
18th Feb 20104:31 pmRNSHolding(s) in Company
9th Feb 20103:04 pmRNSDirector/PDMR Shareholding
8th Feb 201010:10 amRNSHolding(s) in Company
8th Feb 20107:00 amRNSFinal Results
1st Feb 201010:27 amRNSHolding(s) in Company
28th Jan 201010:00 amRNSNotice of Results
4th Jan 20109:01 amRNSHolding(s) in Company
16th Dec 20097:00 amRNSContract to develop & supply military comms
4th Dec 20099:27 amRNSHolding(s) in Company
29th Oct 20097:00 amRNSInterim Management Statement
19th Oct 200912:00 pmRNSDirector/PDMR Shareholding
19th Oct 200911:54 amRNSHolding(s) in Company
19th Oct 200911:54 amRNSHolding(s) in Company
15th Oct 20092:54 pmRNSDirector/PDMR Shareholding
26th Aug 20091:31 pmRNSDirector/PDMR Shareholding
20th Aug 20092:43 pmRNSHolding(s) in Company
13th Aug 20093:36 pmRNSDirector/PDMR Shareholding
4th Aug 20097:00 amRNSHalf Yearly Report
15th Jul 200910:00 amRNSNotice of Results
22nd Jun 20093:42 pmRNSResult of AGM
17th Jun 20097:00 amRNSAGM Statement
10th Jun 200911:37 amRNSHolding(s) in Company
19th May 20093:28 pmRNSAnnual Information Update
14th May 200911:34 amRNSDirector/PDMR Shareholding
12th May 20097:00 amRNSInterim Management Statement
30th Apr 20092:00 pmRNSAnnual Financial Report
31st Mar 20097:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.